DCP
BMY icon

DSM Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

DSM Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,561,095
Closed -$188M – 42
2016
Q2 		$188M Sell
2,561,095
-86,077
-3% -$6.08M 3.24% 12
2016
Q1 		$169M Buy
2,647,172
+773,702
+41% +$48.8M 2.77% 18
2015
Q4 		$129M Buy
1,873,470
+173,702
+10% +$11.5M 2.02% 24
2015
Q3 		$101M Buy
+1,699,768
New +$108M 1.87% 25

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

DSM Capital Partners's BMY Position: Q3 2016 in Review

DSM Capital Partners sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 2,561,095 shares — an estimated $188M sold.

DSM Capital Partners first reported a position in BMY in Q3 2015 and held it in 4 quarters. The position peaked at $188M in Q2 2016. 1,523 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

  • DSM Capital Partners reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
  • DSM Capital Partners sold 2,561,095 Bristol-Myers Squibb shares in Q3 2016, an estimated $188M.
  • DSM Capital Partners first reported a position in Bristol-Myers Squibb in Q3 2015 and held it in 4 quarters.
  • DSM Capital Partners's Bristol-Myers Squibb position peaked at $188M in Q2 2016.
  • 1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on DSM Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.